Top 50 Medical Startup Investors in Australia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Brandon Capital
VC Fund
|
12 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$120M |
|
Artesian VC
VC Fund
|
9 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
7 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Uniseed
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $404k–$22M |
|
Uniseed Ventures
VC Fund
|
5 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Giant Leap Fund
VC Fund
|
4 | Australia, United States, United Kingdom | Seed, Series A | Health Care, Information Technology, Software | $875k–$23M |
|
Breakthrough Victoria
VC Fund
|
4 | Australia, United States, Philippines | Seed, Series A | Health Care, Manufacturing, Biotechnology | $708k–$36M |
|
Stoic VC
VC Fund
|
4 | Australia, United States, United Kingdom | Seed, Series A | Biotechnology, Medical, Health Care | $600k–$16M |
|
Main Sequence Ventures
VC Fund
|
4 | Australia, United States, Philippines | Seed, Series A, Series B | Software, Artificial Intelligence, Manufacturing | $1M–$73M |
|
Transition Level Investments
VC Fund
|
3 | Australia, United States | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $60k–$2.4M |
|
Fund WA
VC Fund
|
3 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Right Click Capital
VC Fund
|
3 | Australia, Singapore, United States | Seed, Series A | Software, SaaS, Information Technology | $200k–$16M |
|
Antler
VC Fund
|
3 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
EVP
VC Fund
|
3 | Australia, New Zealand, United States | Series A, Seed | Software, SaaS, Information Technology | $942k–$5.4M |
|
M8 Ventures
VC Fund
|
2 | Australia | Seed, Pre-Seed, Series A | Health Care, SaaS, Medical | $681k–$8M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, Financial Services, FinTech | $1.7M–$26M |
|
Horizons Ventures
VC Fund
|
2 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Tyson & Blake
VC Fund
|
2 | Australia | Seed | Medical, Facial Recognition, Artificial Intelligence | |
|
Jolimont Global Mining Systems
VC Fund
|
2 | Australia, United States | Seed, Convertible Note | Software, Construction, SaaS | |
|
Purpose Ventures
VC Fund
|
2 | Australia | Seed | EdTech, Medical, Education | $3M–$4M |
|
Kurt Alexander
Angel
|
2 | Australia | Seed | Mining, Retail, Medical | |
|
Carthona Capital
VC Fund
|
2 | Australia, United States, United Kingdom | Seed, Series A, Series B | Software, Financial Services, FinTech | $404k–$50M |
|
Clinton Capital Partners
VC Fund
|
2 | Australia, United States | Seed, Series A | Software, E-Commerce, Health Care | $337k–$5M |
|
Folklore Ventures
VC Fund
|
2 | Australia, United States, New Zealand | Seed, Series A | Software, Information Technology, Apps | $500k–$21M |
|
Blackbird Ventures
VC Fund
|
2 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$35M |
|
Sydney Angels
VC Fund
|
2 | Australia, United States | Seed, Angel, Series A | Software, SaaS, Health Care | $120k–$4.8M |
|
Starfish Ventures
VC Fund
|
2 | United States, Australia, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
Australian Medical Angels
VC Fund
|
2 | Australia, Hong Kong | Seed, Pre-Seed, Series A | Health Care, Machine Learning, Sports | |
|
Larsen Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Seed, Series A, Series B | Software, Education, SaaS | $457k–$31M |
|
Black Sheep Capital
VC Fund
|
1 | Australia, United States | Seed, Series A, Series C | Software, Internet, E-Commerce | |
|
OIF Ventures
VC Fund
|
1 | Australia, United States, Brazil | Series A, Seed | Software, SaaS, Internet | |
|
Prtnr
VC Fund
|
1 | Australia | Seed | Medical, Hospital, Health Care | |
|
Salus Ventures
VC Fund
|
1 | Australia | Seed, Series A | Organic, Robotics, Aerospace | |
|
Watermark Funds Management
VC Fund
|
1 | Australia | Series A | Medical, Software, Health Care | |
|
Washington H. Soul Pattinson
VC Fund
|
1 | Australia | Series A | Software, Hotel, Men's | |
|
Scalare Partners
VC Fund
|
1 | Australia, Singapore, United States | Seed, Pre-Seed | Software, FinTech, Information Technology | |
|
Titanium Ventures
VC Fund
|
1 | United States, China, Australia | Series B, Series C, Series A | Software, Information Technology, Artificial Intelligence | $7M–$120M |
|
Melbourne Angels
VC Fund
|
1 | Australia, United States, New Zealand | Angel, Seed | Biotechnology, Information Technology, Internet | |
|
Square Peg Capital
VC Fund
|
1 | Australia, United States, Israel | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $653k–$72M |
|
Mass Medical Angels
VC Fund
|
1 | United States, Israel, Australia | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | |
|
SG Hiscock
VC Fund
|
1 | Australia | Series A | Software, Legal, Medical | |
|
Stephen Baxter
Angel
|
1 | Australia | Seed, Pre-Seed, Angel | Software, SaaS, Information Technology | |
|
Healthcare Ventures
VC Fund
|
1 | ||||
|
William Welty
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
Lilly Ventures
VC Fund
|
1 | United States, Israel, Australia | Series C, Series B, Series A | Biotechnology, Health Care, Therapeutics | $6M–$65M |
|
Jutech Pty Ltd
Angel
|
1 | Australia | Seed | Mining, Retail, Medical | |
|
QIC BioVentures
VC Fund
|
1 | Australia | Series A | Medical, Health Care, Biotechnology | |
|
Seven West Media
VC Fund
|
1 | Australia, United States | Seed, Series C | Software, Internet, Financial Services | $40k–$25M |
|
CP Ventures
VC Fund
|
1 | Australia, United States, India | Seed, Pre-Seed | Software, Artificial Intelligence, Machine Learning | $350k–$3.9M |
|
Li Ka-shing
Angel
|
1 | United States, United Kingdom, Israel | Series A, Series B, Seed | Health Care, Biotechnology, Food and Beverage | $300k–$50M |
| Access all 188 investors in Australia Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 49
- Round size: Seed $673k–$6.7M; Series A $4.9M–$81M; Series B $5M–$120M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 223
- Round size: Seed $120k–$4M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Living Models — Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $600k–$4.2M; Series A $1.6M–$16M; Series B $404k–$22M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap —
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more...Investment focus
- Industry: Health Care, Information Technology, Software
- Stage:Seed, Series A
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 44
- Round size: Seed $875k–$4.2M; Series A $2.8M–$23M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $9.7M in 2018
Portfolio highlights
- Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
- Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 45
- Round size: Seed $708k–$7.1M; Series A $1.8M–$36M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
- InnovaIVF — InnovaIVF transforms the reproductive technology landscape with innovative solutions.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $600k–$4.2M; Series A $7.6M–$16M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 121
- Round size: Seed $1M–$7.1M; Series A $4.5M–$29M; Series B $13M–$73M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $303M in 2023
Portfolio highlights
- Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
- ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
- Quantum Brilliance — Quantum Brilliance builds diamond-based quantum chips and products that operate at room temperature, enabling mass-deployable quantum technology from data centers to the field.
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 19
- Round size: Seed $875k–$2.4M; Pre-Seed $60k–$1.5M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 7
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Enzide — Plastic without Pollution: What if there was a way to make plastic harmless and go away when it's no longer needed? With Australia's best scientists we’ve developed super enzyme technology that makes this possible.
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 61
- Round size: Seed $200k–$3.6M; Series A $3.3M–$16M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 932
- Round size: Seed $362k–$5.8M; Pre-Seed $100k–$1.3M; Series A $4.6M–$29M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- not8 — not8 is a SaaS platform that helps digital agencies and IT companies save those hours and increase employee productivity by up to 15% by moving all the conversations "inside the product".
- Qeeper — On-demand property maintenance across London, Edinburgh and Brighton
- Cloud Cycle — Globally we produce over 10 billion tons of concrete each year, its the second most consumed material on the planet behind wate and is responsible for upto 10% of global CO2 emissions. Around 5% of all concrete produced goes to waste, this waste in the UK alone costs around £400 million.Cloud Cycle has developed an on-truck device and sensorarray which feeds our cloud platform to ensure concrete meets specification & prevents waste. Even when surplus does still occur, our marketplace for the local on-sale of surplus concrete will find a buyer. We aim to save industry billions whilst reducing global CO2 by 1%.We are using advanced technology & the circular economy to transform the concrete industry.
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 102
- Round size: Seed $942k–$2.5M; Series A $1.2M–$5.4M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- Veridooh — Use Veridooh to increase the effectiveness of your out-of-home advertising with automation, independent verification, and actionable intelligence - all in one easy-to-use, collaborative platform.
- InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
- Deckard Technologies — Deckard Technologies provides city and county governments the analytics and insights they need to ensure tax fairness and equity in their jurisdictions by recovering mandated property and transient occupancy taxes. Using AI and a massive data collection, the Deckard platform performs analysis of hundreds-of-millions of images and data points,giving local governments greater visibility into the commercialization of residential neighborhoods and property upgrades, through two products: Rentalscape and Propertyscape. Deckard’s partnership with local communities saves them time and money, increases productivity, and enables them to make informed policy decisions while determining their own thresholds for the sharing economy. The recovered taxes support the common good of the local communities, including essential services like schools, infrastructure, fire departments, and safety.
Great tech startup businesses are built by amazing product teams
Show more...Investment focus
- Industry: Health Care, SaaS, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 5
- Round size: Seed $3M–$8M; Pre-Seed $681k–$1M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- Flowing Bee — Revolutionise your customer interactions using AI, customer and behavioural insights. We create powerful marketing communications that drive behaviour change.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Carma — Want to sell or trade in your old car? Good news: Carma takes care of both! Get a valuation online, with easy drop-off and seamless transition between cars.
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Amaero International — Amaero International is a manufacturer of high-temperature powder metals and specialty powders. The company produces refractory, titanium, and specialty alloyed powders using gas atomization and hot isostatic pressing (HIP) technologies. Amaero International serves sectors including defense, aerospace, energy, and medical.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 250
- Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more...Investment focus
- Industry: Medical, Facial Recognition, Artificial Intelligence
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more...Investment focus
- Industry: Software, Construction, SaaS
- Stage:Seed, Convertible Note
- Geography: Australia, United States
Investor stats
- Total investments: 5
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
- APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more...Investment focus
- Industry: EdTech, Medical, Education
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 5
- Round size: Seed $3M–$4M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kurt Alexander
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 111
- Round size: Seed $404k–$4.2M; Series A $3.3M–$17M; Series B $9.8M–$50M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
- CoverRight — Use CoverRight's tools to find a personalized Medicare plan and get the best coverage for your situation! Compare and enroll in Medicare Advantage, Medigap, and Prescription Drug Plans, all in one place.
- Lounge — Use Lounge to organise events and groups in seconds, without a newsfeed. Stop scrolling, start living.
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 65
- Round size: Seed $337k–$2.4M; Series A $740k–$5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 45
- Round size: Seed $725k–$5M; Series A $500k–$21M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
- Sphere — Live courses led by vetted experts for professionals who want to advance their careers
- Visionary Machines — Superior perception for next-generation autonomy
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 306
- Round size: Seed $34k–$7M; Pre-Seed $50k–$3M; Series A $3.3M–$35M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- Polymath — Personalised learning and fun means you can be confident that your child is getting the learning experience they want and deserve.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 93
- Round size: Seed $120k–$1.3M; Angel $130k–$890k; Series A $250k–$4.8M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: United States, Australia, Philippines
Investor stats
- Total investments: 53
- Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $134M in 2008
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more...Investment focus
- Industry: Health Care, Machine Learning, Sports
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, Hong Kong
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence We like metrics, traction & perseverance We invest in people 1/3 of our focus is on Health and Education; We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research, chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction Founders with Insight Founders with Perseverance and Courage Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey Accelerate your business with our portfolios' intellectual capital
Show more...Investment focus
- Industry: Software, Education, SaaS
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $457k–$8M; Series A $500k–$15M; Series B $4.4M–$31M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Vitruvian Form — Vitruvian manufactures a connected fitness hardware, develops software and fitness class content.
Black Sheep Capital is making its mark as a preferred investment capital provider due to their 'Everyone Wins' approach. Their philosophy is to work with their investment partners to create and grow opportunities where they can all enjoy success. Through this approach, they have been able to create a diverse portfolio of investments thatcontinues to grow.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Series A, Series C
- Geography: Australia, United States
Investor stats
- Total investments: 42
- Lead/follow: no public data
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Kleecks — Kleecks is an innovative SaaS platform that optimises performance marketing activities, improves website health and speed in real-time, and has a significant impact on businesses by increasing revenues, lowering costs, and accelerating time-to-market
- Project Manda — Transform your workspace with Project Manda's AI-driven platform. Analyse company meetings, receive actionable recommendations, and boost staff productivity and ROI
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!OIF is a venture capital firm focusing on partnering with entrepreneurs building businesses.
Show more...Investment focus
- Industry: Software, SaaS, Internet
- Stage:Series A, Seed
- Geography: Australia, United States, Brazil
Investor stats
- Total investments: 55
- Lead/follow: no public data
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Nullify — Nullify performs product security tasks alongside your developers.
- LoveHeart — LoveHeart is an AI educator-aide that streamlines child development documentation. Write learning stories, journals, plans, and reflections in seconds. Trusted by leading educators. Get your team plan today.
Prtnr is an investment firm.
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
Salus Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Organic, Robotics, Aerospace
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- Q-CTRL — Infrastructure software to power the quantum future
- ExoFlare — ExoFlare is built for intensive agri industries, transforming biosecurity from a compliance burden into a strategic advantage. Streamline and protect operations. Maintain market and capital access. Stay in business during incursions. Thrive amid escalating biosecurity risks.
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
With origins in owning and operating Australian pharmacies, Soul Patts has evolved into a diversified investment house investing across a range of industries and asset classes, including listed equities, private equity, credit, and property.
Show more...Investment focus
- Industry: Software, Hotel, Men's
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
Scalare Partners is more than a technology investment fund. We provide critical funding and resourcing
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- Brauz — Brauz connects your customers now with Reserve In Store, Find in Store, Click + Collect, On Demand Delivery, Ship from Store, Appointment Booking, Video Commerce, Clienteling and more.
- Betterx — Betterx is a technology company focused on infrastructure to support Web3.0 and Digital Assets.
- Amelio Health — Amelio Health is a program integrating a set of pathways developing the capabilities of case managers to signpost claimants at risk of developing chronic pain
Titanium Ventures is the results-oriented VC partner to the most promising technology startups. Accelerating extraordinary companies and fueling growth of standout disruptors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series B, Series C, Series A
- Geography: United States, China, Australia
Investor stats
- Total investments: 143
- Round size: Series A $7M–$30M; Series B $10M–$85M; Series C $18M–$120M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- Gago — Gago Ltd., a big data company based in Beijing China, is specialized in environmental and agricultural data collection, analysis and application. Through image data collected from satellites and drones, Gago incorporates weather, farm land, crop growth, etc. to enable precision and digital farming practices. Gago provides data services andsolutions to governments, mid/large-scale farm owners, upstream/downstream related producers and ag financial institutions.Through SaaS platform, Gago provides data to support farming decisions, including field positioning, crop planning, growth monitoring, yield analysis, disease/pest control and prevention, irrigation planning, machine deployment, financing solutions and so on. Gago aims to promote transparent and data-driven agricultural practices.
- Springboard — Springboard is an online learning platform that prepares students for the tech industry’s most sought after careers. With expert mentorship from top professionals, a bleeding-edge curriculum, and a network of support from day one, they make sure students have everything they need to excel in their program and in their next job. The platformone-size-fits-one approach is made for working professionals who are ready to level-up or make a major career shift. And our tuition back guarantee means students can take charge and invest in themselves.Springboard data science career track comes with a job guarantee, ensuring students secure a job within six months of graduation or get a full refund. The platform's self-paced courses offer students the opportunity to develop job-ready skills that they display in an industry-worthy capstone or portfolio projects.
- vArmour — VArmour offers data-defined perimeter security solutions for mobile, virtual, and cloud platforms. It specializes in the fields of cybersecurity, mobile, software, and the internet. The company was founded in 2011 and is based in Mountain View, California.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Internet
- Stage:Angel, Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 40
- Lead/follow: no public data
Portfolio highlights
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Square Peg is a global investment firm on a mission to empower exceptional founders. With investing teams in Sydney, Melbourne, Tel Aviv, and Singapore, Square Peg invests in emerging technology companies across the internet economy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 173
- Round size: Seed $653k–$12M; Series A $2.7M–$34M; Series B $10M–$72M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Neara — Beyond visualization. A geometrically precise, 3D model that reveals how assets behave and react in the real world
- Pluang — Investasi di Saham AS, Kripto, Emas & Reksa Dana mulai Rp5.000. Aman, teregulasi, dan mudah digunakan.
- Excelero Storage — Founded in 2014 by a team of storage veterans and inspired by the Tech Giants’ shared-nothing architectures for web-scale applications, the company has created a Software-Defined Block Storage solution that meets performance and scalability requirements of the largest web-scale and enterprise applications.With Excelero’s NVMesh, customers canbuild distributed, high-performance Server SAN for mixed application workloads. Customers benefit from the performance of local flash, with the convenience of centralized storage while avoiding proprietary hardware lock-in and reducing the overall storage TCO. The solution has been deployed for hyper-scale Industrial IoT services, machine learning applications and massive-scale simulation visualization.
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Australia
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
- Capillary Biomedical — Make diabetes management easier with insulin pumps and other innovative products and services from Tandem Diabetes Care.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SG Hiscock
Show more...Investment focus
- Industry: Software, Legal, Medical
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
- Immediation — Sophisticated video conferencing for dispute resolution and legal practice. Built by Lawyers, for Lawyers. Start your free 14-day trial today.
- Marketplacer — Marketplacer is a marketplace platform and dropshipping solution that allows enterprise companies to scale and grow in today's evolving e-commerce environment.
Stephen Baxter - Founder @ River City Labs
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed, Angel
- Geography: Australia
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Travelshoot — Your holidays are really important to us to create good memories and we are offering Worldwide Photographer Services. Get the best vacation photographer NYC & across the globe. Visit us now!
- Car Next Door — Hire a car, van or ute from our community of local car owners, or rent out your car and make extra money. Peer-to-peer car share in Sydney, Melbourne, Newcastle.
Healthcare Ventures is an investment fund that invests in people and technologies that focuses on the data and technology of healthcare. Healthcare Ventures specializes in the fields of venture capital, private equity, and financial services.
Show more...Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Evidentli — Our technology standardises complex healthcare data with over 99% accuracy in days, not months; in weeks, not years.
William Welty
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series C, Series B, Series A
- Geography: United States, Israel, Australia
Investor stats
- Total investments: 70
- Round size: Series A $8.9M–$35M; Series B $15M–$65M; Series C $6M–$55M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
- Evox Therapeutics — Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectualproperty portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families.Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.
- Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines
Jutech Pty Ltd
Show more...Investment focus
- Industry: Mining, Retail, Medical
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Change the tagline
Show more...Investment focus
- Industry: Software, Internet, Financial Services
- Stage:Seed, Series C
- Geography: Australia, United States
Investor stats
- Total investments: 20
- Round size: Seed $40k–$3.4M; Series C $1.3M–$25M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Carbar — Buy, finance or subscribe to your next car online. Sell your car without haggling, get an instant valuation.
- InStitchu — InStitchu is an online custom clothier specializing in tailor made menswear. Customers are able to design custom made garments online which are then made to their exact measurements.InStitchu provides tailor made, high quality menswear through a simple online ordering process. Once a customer has added measurements to their profile, a suit orshirt can be ordered in a few minutes and on its way in two weeks. There are multiple ways for a customer to get their measurements perfected and enjoy that “perfect fit” InStitchu customers keep coming back for - our measurement guide will take you on a journey from your living room to the hustle and bustle of our tailor’s studio. Customers can choose from a wide range of globally sourced high quality wool and cotton fabrics, and when you’ve chosen, we’ll deliver your design right to your door. This new approach to shopping is stress free and cuts out the middleman, allowing us to deliver customers luxury tailor made suits and shirts without the high price tag.
- CarExpert.com.au — Australia's most reputable and independent motoring experts bring you the latest car reviews, comparisons, news and auto content.
The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed
- Geography: Australia, United States, India
Investor stats
- Total investments: 57
- Round size: Seed $417k–$3.9M; Pre-Seed $350k–$900k
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Mr. Li Ka-shing is the richest person of East Asian descent in the world and the 11th richest person in the world with an estimated wealth of US$26 billion (as estimated by Forbes). His primary operating company is Hutchison Whampoa Limited. Mr Li's younger son, Richard, is Chairman of PCCW, one of Asia's leading internet andtelecommunications companies.Mr Li Ka-shing is the Chairman of Cheung Kong (Holdings) Limited and Hutchison Whampoa Limited. Cheung Kong (Holdings) Limited is the flagship of the Cheung Kong Group which has business operations in 54 countries around the world and employs about 240,000 staff. In Hong Kong alone, the Group includes nine listed companies with a combined market capitalization of approximately HKD600 billion (30 June 2009). Hutchison Whampoa Limited is a Fortune Global 500 company.Born in 1928 in Chiu Chow, a coastal city in the southeastern part of China, Mr Li fled to Hong Kong with his family to avoid the perils of war. His father suffered from tuberculosis and passed away in Hong Kong. Shouldering the responsibility of looking after the livelihood of the family, Mr Li was forced to leave school before the age of 15 and found a job in a plastics trading company where he labored 16 hours a day. By 1950, his hard work, prudence and his pursuit of excellence had enabled him to start his own company, Cheung Kong Industries. From manufacturing plastics, Mr Li led and developed his company into a leading real estate investment company in Hong Kong that was listed on the Hong Kong Stock Exchange in 1972. Cheung Kong continued to expand by acquiring Hutchison Whampoa and Hongkong Electric Holdings Limited in 1979 and 1985 respectively.Based in Hong Kong, the Cheung Kong Group's businesses encompass such diverse areas as property development and investment, real estate agency and estate management, hotels, telecommunications and e-commerce, finance and investments, retail, ports and related services, energy, infrastructure projects and materials, media, and biotechnology. Mr Li is a strong believer in synergy — the power of combined efforts. This belief is reflected in his naming his company Cheung Kong Holdings after the Yangtze River that flows through China, a great river that aggregates countless streams and tributaries. The Times in the United Kingdom and Ernst & Young UK jointly named Mr Li as the Entrepreneur of the Millennium at the turn of the century.http://www.hutchison-whampoa.com/eng/about/chairman/chairman.htm 30 June 2009
Show more...Investment focus
- Industry: Health Care, Biotechnology, Food and Beverage
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 25
- Round size: Seed $300k–$11M; Series A $21M–$50M; Series B $15M–$50M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- H2Pro — H2Pro is a renewable energy company that is working on an efficient green hydrogen production method - E-TAC. Its mission is to enable the wide-scale adoption of sustainable hydrogen fuel by introducing a novel water-splitting technology.
- Omni — Omni aims to revolutionise mobility in cities and campuses by empowering residents with cleaner, more efficient, and affordable transportation options that improve urban sustainability in the United Kingdom. By systematically deploying thousands of smart-bikes, enabled with GPS, wireless technology, and self-locks, we will dramatically improveurban mobility by making the first and last mile faster, cheaper, and healthier. We take city and school friendly approach and seek for partnership to work on this challenging problem.
- Fertilis — Fertilis: A better way to care for your embryos in an IVF clinic. Fertilis technology involves each embryo growing inside its own patented micro-3D printed pod. The pod protects the embryo and enables automated subtle changes to the nutritive composition of the solutions that bathe the embryo.
Medical Investor funding in Australia at a glance
Stats across 167 deals from 188 investors.
Access all 188 investors in Australia Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 188 investors investing in Australia Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!